Laurus Labs Founder Sees Strong CDMO Pipeline With More Than 100 Active Projects

Speaking to NDTV Profit on Monday, the leading pharma company’s founder and CEO, Dr Satyanarayana Chava, expressed confidence in Contract Development and Manufacturing Organisation business growth and said CDMO segment could contribute nearly 50% of the company’s revenue in the medium to long term. Tune in to find out more.